𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Surgical treatment of recurrent pleomorphic adenoma of the parotid gland: A clinical analysis of 52 patients

✍ Scribed by Afina S. Glas; Albert Vermey; Harry Hollema; Peter H. Robinson; Jan L.N. Roodenburg; Raoul E. Nap; John Th. M. Plukker


Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
97 KB
Volume
23
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Background

Surgical management of recurrent pleomorphic adenoma of the parotid gland has a considerable risk of facial nerve injury and a high re‐recurrence rate. To obtain more insight into this issue we evaluated our experiences.

Methods

Medical records and histologic material of all these patients (31 women and 21 men), who had been treated from 1976–1995 were reviewed. Median interval between initial treatment and commencement of recurrences was 3 (0.8–18) years. Last surgery consisted of parotidectomy in 48 patients (92%), including 19 (40%) total procedures and wide local excision with involved skin in four patients.

Results

At a median follow‐up of 9 years, eight patients (8/52; 15%) had re‐recurrences develop, including 4 of 21 patients (19%) after a previous parotidectomy (group I) and 4 of 31 patients (13%) without prior parotidectomy (group II). The chance of re‐recurrence in a group of patients with a minimal follow‐up of 10 years after salvage surgery was 17% (4 of 24). The risk of a new relapse was, respectively, 4% and 8% at 1 and 5 years after treatment of recurrent disease. Acceptable N.VII function was preserved in 45 of the 49 (92%) nerves at risk. The risk of N.VII injuy was higher and more serious in group I (29% vs 10% in group II). The function of four of the five (80%) reconstructed zygomaticotemporal branches of the N.VII was adequate.

Conclusion

Surgical treatment of recurrent pleomorphic adenoma of the parotid gland, usually consisting of a parotidectomy with wide extent and eventually facial nerve reconstruction, demonstrates favorable results with acceptable morbidity. The risk of new relapse and N.VII injury was higher after previous parotidectomy. Β© 2001 John Wiley & Sons, Inc. Head Neck 23: 311–316, 2001.


πŸ“œ SIMILAR VOLUMES


Recurrent pleomorphic adenoma of the par
✍ Claus Wittekindt; Kristina Streubel; Georg Arnold; Eberhard Stennert; Orlando Gu πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 137 KB

## Abstract ## Background Surgery for recurrent parotid pleomorphic adenoma is a challenging problem. ## Methods One hundred eight patients who underwent 134 reoperations for recurrent parotid pleomorphic adenoma (follow‐up, 22 years) were evaluated for histopathologic features and risk factors

Controversies. Recurrent pleomorphic ade
✍ Roger Boles; Carl A. Patow; Oscar M. Guillamondegui πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 441 KB

The remainder of the examination is unremarkable. Fine-needle aspiration of the mass confirms pleomorphic adenoma which is consistent with the pathology of the original tumor.

Benign metastasizing pleomorphic adenoma
✍ Gino Marioni; Filippo Marino; Roberto Stramare; Rosario Marchese-Ragona; Alberto πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 286 KB

## Abstract ## Background. Pleomorphic adenoma constitutes the most common benign parotid gland tumor. Local recurrence after surgical treatment (lateral or total parotidectomy) has been described in 1% to 5% of cases. Malignant degeneration has been reported in 2% to 9% of cases of pleomorphic ad